Explore More Than Just This Free Article

This article is a glimpse of the exclusive insights we provide daily to industry leaders. Dive deeper into our industry-specific reports and uncover the strategic information you need.

Industry Intelligence needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Reminder: Invitation to Roche’s Virtual Neurology Investor Event

March 4, 2024 (press release) –



 


 

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 11 March 2024, highlighting key data presented at 2024 Muscular Dystrophy Association (MDA) and Alzheimer's & Parkinson's Diseases (AD/PD) conferences.

 

15:00 – 16:30 CET / 14:00 – 15:30 GMT
10:00 – 11:30 AM EDT / 07:00 – 08:30 AM PDT

 

The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CET on the day of the event. >click here

 

Agenda

Welcome
Bruno Eschli, Head of Investor Relations

Neurology franchise update
Paulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Cardiometabolic, Infectious and Rare Diseases Clinical Development

Review of key EMBARK data presented at MDA
Alex Murphy, Senior Clinical Director

Review of key trotinemab and prasinezumab data presented at AD/PD
Azad Bonni, MD, PhD, Senior Vice President and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development

Q&A

 

Access to virtual event (pre-registration required)
Please pre-register for our webinar here.*

 

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

 

A replay of the webinar will be available via > ir.roche.com
*privacy notice

 

Best regards,

 
Bruno Eschli
Head of Investor Relations

 
Loren Kalm
Head of Investor Relations, North America
 


Roche Investor Relations  
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
 
   
Investor Relations North America  
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

 


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo with Dan
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.